Author: admin

  • Champions League qualifying: Fixtures, dates, how it works – UEFA.com

    1. Champions League qualifying: Fixtures, dates, how it works  UEFA.com
    2. Champions League first qualifying round: The long road to Budapest begins  BBC
    3. Champions League predictions | Latest betting and odds for winners, finalists for 2025/26 season  sportingnews.com
    4. Champions League qualifying kicks off as Finland’s KuPS and Sweden’s Malmo win first-leg games  FOX Sports
    5. UEFA Champions League 2025/26 season starts today  Yahoo Sports

    Continue Reading

  • Two Doses of Recombinant Zoster Vaccine Worked Well in People 50 and Older – NEJM Journal Watch

    1. Two Doses of Recombinant Zoster Vaccine Worked Well in People 50 and Older  NEJM Journal Watch
    2. Study estimates 74% efficacy of shingles vaccine in patients over 50  CIDRAP
    3. Shingrix Vaccine Reduces Herpes Zoster Risk By 50% in Inflammatory Arthritis  Vaccine Advisor
    4. Why the Shingles Vax Is Important for Your Cardio Patients  Medscape

    Continue Reading

  • Jax Taylor gets honest about his sobriety journey

    Jax Taylor gets honest about his sobriety journey

    Jax Taylor reflects on his battle with drugs

    Jax Taylor is doubling down on his effort to take drugs out of his life as he reflects on his sobriety journey.

    In a podcast with We’re Out of Time, the reality star said, “I know for a fact — and I know you’re not supposed to say it — but I know for a fact I will not touch drugs and alcohol again. I know that. I have no interest in it. I’m not triggered by it.“

    “But so now I can look back and say, ‘What the **** was I doing?’ ” he added. “‘Why didn’t I stop this years ago?’“

    In response, the host Richard Taite asked, “If you stop working out, will you look like this in three, four months?”

    “No,” he said. “I’m going to always work on it … I want to make it very clear, I’m not going to ever stop going to AA for the rest of my life. I love it. It’s like a drug to me.”

    “I love going and meeting the guys. My sober friends, I’ve shifted from my drunk friends, now I have a sober group of friends. We have a great time. We go out to dinner.“

    Moreover, the Vanderpump Rules alum said, “I like to be home on my couch watching my shows. But I’ll give myself a 45-minute window.”

    Capping off, Jax shared, “I’m feeling great right now, as far as my health.”


    Continue Reading

  • Remarks of Commissioner Kristin N. Johnson at George Washington University

    Remarks of Commissioner Kristin N. Johnson at George Washington University

    Thank you to the George Washington University Regulatory Studies Center, Roger Nober, Susan Dudley, and the organizers of today’s event for allowing me to join virtually. As many of you are aware, I have spent the last several years engaging regulators and market participants from jurisdictions around the world on issues at the core of today’s discussion.[1]

    How might advances in artificial intelligence (AI) increase inclusion and customer experiences and democratize access to financial services, improve the accuracy and efficiency of financial services, and potentially reduce transaction costs as well as the costs of compliance? 

    These issues, among several other potential benefits and risks associated with the adoption of innovative technologies, are top of mind for me and many other senior regulators, chief executive officers, chief technology officers, chief information security officers, chief compliance officers, and chief risk managers around the world.

    According to an International Monetary Fund paper exploring the benefits and risks of AI in finance, AI and machine learning (ML) technologies alongside other

    [r]ecent technological advances in computing and data storage power, big data, and the digital economy are facilitating rapid AI/ML deployment in a wide range of sectors, including finance. The COVID-19 crisis has accelerated the adoption of these systems due to the increased use of digital channels.

    AI/ML systems are changing the financial sector landscape. Competitive pressures are fueling rapid adoption of AI/ML in the financial sector by facilitating gains in efficiency and cost savings, reshaping client interfaces, enhancing forecasting accuracy, and improving risk management and compliance. AI/ML systems also offer the potential to strengthen prudential oversight and to equip [regulators]  with new tools. . . .[2]

    Indisputably, AI is rapidly transforming the financial sector, particularly in the areas of compliance, market surveillance, and regulatory enforcement. What once seemed the creative imaginings of science fiction or fantasy novels and films—forward-looking notions of a futuristic world—has now become a practical and increasingly essential tool across the financial market ecosystem. Market participants and regulators alike are leveraging AI and ML to improve risk management, detect misconduct, and strengthen the integrity of the markets.

    Let’s explore the use of AI in compliance, bad actors’ potential misuse of AI, opportunities for supervisory technology (suptech) in enforcement, and a path forward.

    AI and Industry Compliance

    Financial institutions have been at the forefront of AI adoption, especially in compliance functions. AI is widely used in anti-money laundering (AML) efforts, where algorithms analyze transaction patterns across millions of credit card statements, bank statements, and account details to detect anomalies that may go unnoticed by traditional systems. ML models have dramatically reduced false positives in AML alerts[3]; this has long been a challenge for compliance teams who may now rely on AI to learn by reviewing training data and distinguish between benign and suspicious activity more precisely and more efficiently.

    AI also supports compliance with complex cross-border financial regulations. Financial services firms deploy ML to monitor transactions for potential sanctions violations, helping ensure that transactions align with regulatory requirements based on origin, amount, frequency, and other risk factors.[4]

    Some firms have also embraced AI in communications surveillance, using platforms that offer digital communications governance to review internal communications for signs of fraud or misconduct. By automating these reviews, firms are better equipped to identify red flags early and maintain robust compliance programs.

    A recent Government Accountability Office (GAO) report released in May of 2025—Artificial Intelligence: Use and Oversight in Financial Services—identifies six increasingly common activities for which financial services firms may choose to integrate AI models, including automated trading, countering threats and illicit finance, credit decisions, customer service, investment decisions, and risk management.[5]

    The GAO report indicated that AI may be used to “detect and mitigate cyber threats through real-time investigation of potential attacks, flagging and blocking of new ransomware, and identification of compromised accounts and files” as well as to “identify fake IDs, recognize different photos of the same person, and screen clients against sanctions and other lists; analyze transaction data … and unstructured data (such as email, text, and audio data) to detect evidence of possible money laundering, terrorist financing, bribery, tax evasion, insider trading, market manipulation, and other fraudulent or illegal activities.”[6]

    For many of these use cases, financial services firms rely on generative AI. However, for use cases that require a high degree of reliability or explainability—the ability to understand how and why an AI system produces decisions, predictions, or recommendations—firms are rightly reticent to employ generative AI models.

    Regulators Use of AI for SupTech 

    The benefits of AI are not limited to the private sector. U.S. regulatory agencies—including the Commodity Futures Trading Commission (CFTC), the Board of Governors of the Federal Reserve System (Federal Reserve), the Federal Deposit Insurance Corporation (FDIC), the Securities and Exchange Commission (SEC), and the National Credit Union Administration (NCUA)—have begun integrating AI tools into their supervisory functions.

    These agencies use AI to analyze vast quantities of financial data, identify outliers, and detect emerging risks.[7] For example, AI can flag inconsistencies in data submissions from financial institutions, or surface patterns that indicate potential regulatory violations. This use of AI, often referred to as “suptech” (supervisory technology), enhances regulators’ ability to carry out their oversight responsibilities efficiently and proactively.

    Over the course of last year, the CFTC undertook extraordinary efforts to begin to clarify the Commission’s understanding of registrants’ use of AI and the potential benefits and limitations of the Commission’s implementation of AI for supervisory, surveillance, and enforcement purposes. In January of 2024, I worked with Commission staff to issue a Request for Comment distributed to our market participants to better understand the real-time adoption of AI models.[8] Following the Request for Comment, in December of 2024, the Commission issued a staff advisory on Use of Artificial Intelligence in CFTC-Regulated Markets.[9] One of the most significant takeaways from the staff advisory, which was echoed in executive orders issued by the prior administration, underscore the obligation for CFTC-regulated entities to maintain compliance with applicable statutory and regulatory requirements whether they choose to deploy AI or any other technology.

    Addressing the Dark Side of AI

    While AI has the potential to enhance compliance and supervision, it also introduces new risks. Alongside the promise of AI, we must consider the limitations and potential perils of implementing AI quickly without appropriate guardrails. Many of you in the room today, former Commissioner Berkovitz and Professor Cary Coglianese, among others, have participated in joint studies published by the Administrative Conference of the United States (ACUS) or independently published or presented on these limits. 

    In previous speeches, I have outlined concerns regarding the implementation of AI models without effective guardrails and governance interventions. 

    In a speech earlier this summer, I began to explore the specific concerns that may emerge as firms and regulators integrate agentic AI.[10] The discussion today, in fact, may largely focus on the integration of agentic AI models in compliance, surveillance, and enforcement. If so, I am hopeful that, in parallel to efforts to explore the benefits, panelists examining “AI’s Role in Regulation Post-Chevron” and “Regulatory Functions Most Amenable to AI-Drive Process Improvement” will also examine important concerns such as the limits of synthetic data, ghosts or hallucinations, data leakage, increasingly undetectable video and voice deepfakes, data accuracy, data security, and data integrity, among others.

    Some bad actors are paving the road for regulators and enforcement actions using AI technology. . But, in many cases, the bad actions are simply traditional, garden variety fraud with an AI white-label. 

    “AI washing”—the practice of exaggerating or misrepresenting AI capabilities to attract investors or customers[11]—is among the most concerning marketing and solicitation issues that financial market regulators currently face. Firms may claim to use advanced AI models to generate high returns when, in reality, they rely on rudimentary trading bots or nonexistent systems.[12]

    Enforcement in Action

    The CFTC has actively pursued enforcement actions against fraudulent actors who misuse or misrepresent AI. In a landmark case, the Commission obtained a $1.7 billion penalty—its largest ever—against a South African company that defrauded investors through a fraudulent multilevel marketing scheme.[13] The company falsely claimed to use a proprietary AI trading bot to generate high returns on Bitcoin investments. In reality, there was no proprietary trading bot and the firm engaged in minimal trading activity, most of which was unprofitable, and misappropriated investor funds.

    This and other cases underscore the CFTC’s ability to tackle AI-related misconduct using existing legal tools. The Commodity Exchange Act (CEA) provides a robust and flexible framework that prohibits fraudulent and manipulative practices regardless of the underlying technology. For example, CEA Section 4c(a) outlaws disruptive practices such as spoofing,[14] while CEA Section 6(c)(1) and Regulation 180.1 give the Commission broad anti-fraud and anti-manipulation authority.[15] These provisions are intentionally technology-neutral, allowing the CFTC to remain agile as new innovations emerge.

    The Commission has demonstrated, through its prior enforcement actions, that markets and market participants engaged in activities that are regulated by the Commission are expected to comply with applicable statutory and regulatory requirements, even when such activities occur with cryptocurrencies or through the use of AI. The technology-neutral approach of the CEA and CFTC regulations allows these provisions to be used to combat fraud in any shape, manner, or form.

    The Strategic Importance of Suptech

    A recent survey by the Financial Stability Institute (FSI) and the Bank for International Settlements Innovation Hub found that only 3 out of 50 supervisory authorities surveyed did not have ongoing suptech initiatives.[16] Those with a comprehensive suptech strategy were significantly more likely to deploy tools critical to supervision.[17]

    This underscores the importance of not only embracing AI on a case-by-case basis, but also developing cohesive strategies for integrating AI into regulatory and supervisory workflows. By investing in data infrastructure, fostering inter-agency collaboration, and recruiting AI-savvy talent, regulators can better equip themselves to meet the demands of increasingly complex markets.

    Finding a Pathway Forward

    I am looking forward to exploring the following principles and their role in our principles-based regulatory framework that I outlined in a speech last year. [18] As I have previously explained, there are many things that the Commission can do immediately to enhance our understanding of AI and help guide the development of effective guardrails that foster responsible development of AI.[19]

    Heightened Penalties

    As a CFTC Commissioner, I am also deeply concerned about the potential for abuse of AI technologies to facilitate fraud in our markets. As we examine the development of and limitations on the legitimate uses of AI in our markets, it is also important for the CFTC to emphasize that any misuse of these technologies will draw sharp penalties.

    In fact, I continue to call for the Commission to consider introducing heightened penalties for those who intentionally use AI technologies to engage in fraud, market manipulation, or the evasion of our regulations.

    In many instances, our statutes provide for heightened civil monetary penalties where appropriate.

    I propose that the use of AI in our markets to commit fraud and other violations of our regulations may, in certain circumstances, warrant a heightened civil monetary penalty.

    Bad actors who would use AI to violate our rules must be put on notice and sufficiently deterred from using AI as a weapon to engage in fraud, market manipulation, or to otherwise disrupt the operations or integrity of our markets. We must make it clear that the lure of using AI to engage in new malicious schemes will not be worth the cost.

    Recommendation for an Inter-Agency Task Force

    At the end of 2023, the previous administration announced the creation of an AI Safety Institute, which was to be established within the National institute of Standards and Technology (NIST), housed within the Commerce Department.[20]

    Shortly thereafter, I proposed the creation of an inter-agency task force composed of financial regulators including the CFTC, SEC, Federal Reserve, Office of the Comptroller of the Currency, Consumer Financial Protection Bureau, FDIC, Federal Housing Finance Agency, and NCUA to develop guidelines, tools, benchmarks, and best practices for the use and regulation of AI in the financial services industry.[21]

    Addressing the perils of AI, while harnessing its promise, is a challenge that will require a whole-of-government approach, with regulators working together across diverse agencies. I continue to advocate for agencies working together to provide their essential experience and expertise to help guide the development of AI standards for the financial industry.

    Conclusion

    The CFTC, in particular, is well positioned to lead in this space. Its principles-based and technology-neutral approach to regulation allows for flexible oversight that supports innovation while safeguarding market integrity. The Commission’s mission—to foster open, transparent, competitive, and financially sound markets—naturally aligns with the adoption of cutting-edge technology.

    AI is no longer a futuristic concept—it is a central feature of modern financial markets. Used responsibly, AI enhances compliance, improves oversight, and enables faster and more effective enforcement. The CFTC’s technology-neutral framework allows it to keep pace with innovation while maintaining essential investor protections and market integrity.

    Thanks again for allowing me to share my thoughts with you today. I anticipate you will have an energetic, generative, and thoughtful discussion on the panels and following the presentations this afternoon.


    [1] The views I share today are my own and not the views of the Commission, my fellow Commissioners or the CFTC staff.

    [15] 7 U.S.C. § 9(1); 17 C.F.R. § 180.1.

    Continue Reading

  • SECP achieves milestones in Corporate registry during FY 2025





    SECP achieves milestones in Corporate registry during FY 2025 – Daily Times





























    Continue Reading

  • Researchers Find Compound That Inhibits Cutaneous HPVs

    Researchers Find Compound That Inhibits Cutaneous HPVs

    Highlights:

    • Human papillomaviruses, or HPVs, cause cutaneous and mucosal infections that may lead to cancer.
    • To date, no antiviral treatment options exist for HPVs.
    • Researchers have identified a promising new compound that inhibits cutaneous HPV.
    • In lab studies, the compound inhibited viral replication genes in cutaneous HPVs without damaging host cells.

    Washington, D.C.-Human papillomaviruses, or HPVs, can cause dangerous infections in the skin and mucous membranes and may lead to cancer. Vaccines that prevent mucosal HPV infections aren’t effective against cutaneous infections, which can cause serious diseases, particularly in immunocompromised people.

    This week in Journal of Virology, researchers describe a small molecule compound, called NSC51349, that in lab tests has shown promise as an antiviral treatment against cutaneous HPVs. The compound blocks viral replication by targeting a critical protein, and the researchers found that it reduced viral load without harming host cells.

    “The inhibitor may represent a new class of HPV-specific antiviral drugs with significant potential,” said molecular virologist and study leader Alla Piirsoo, Ph.D., at the University of Tartu, in Estonia. “Unlike [HPV] vaccines, which rely on the functioning immune system our strategy could benefit people with compromised immunity who currently have very limited therapeutic options.”

    Researchers have identified hundreds of different types of HPVs. Though most infections remain harmless and asymptomatic, infections from high-risk HPVs can lead to cervical cancer and head and neck cancers. Others can cause skin lesions including macule and warts, and when combined with other carcinogens can lead to non-melanoma skin cancer. Existing vaccines that target high-risk types of mucosal HPVs are widely available, but these vaccines are ineffective against cutaneous HPV types.

    A treatment for cutaneous HPV could help a broad patient population, said Piirsoo. “Such a drug could be especially beneficial for immunocompromised individuals, such as organ transplant recipients, patients undergoing immunosuppressive cancer therapy, HIV-positive individuals and people with rare genetic disorders.”

    Piirsoo’s lab studies HPV replication and how it interacts with host cells, with a focus on identifying ways to inhibit viral activity that confer the least harm to the host. For the new work, the researchers used high-throughput screening to test more than 1,500 chemicals for their efficacy against HPV type 5, a cutaneous type of HPV that primarily affects epithelial skin cells and has been associated with increased risk of skin cancer.

    They narrowed in on NSC51349, which in further tests inhibited viral replication of HPV 5 in U2OS cells, osteosarcoma cells often used in cancer research. Further analyses showed that the compound also disabled transcription from the viral genome. Models suggested that the compound worked primarily through mechanisms present in cutaneous HPV types, but not in mucosal ones. The team identified a second small molecule that inhibited both mucosal and cutaneous HPV types, but the compound proved toxic to host cells.

    Subsequent tests showed that NSC51349 also inhibited 2 additional cutaneous types, HPV8 and HPV38. “The compound may have broad-spectrum activity against multiple cutaneous HPV types without harming host cells,” Piirsoo said.

    Bolstered by these promising but early results, the researchers are now working to find the optimal concentration of the compound that inhibits viral replication without harming the host. They’re also planning animal testing, and “if the compound works in the animal model, it would be strong evidence that it could be developed into an effective antiviral treatment for HPVs,” Piirsoo said.

    /Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.

    Continue Reading

  • Estrogen-only hormone therapy lowers young-onset breast cancer risk

    Estrogen-only hormone therapy lowers young-onset breast cancer risk

    Estrogen-only hormone therapy lowers young-onset breast cancer risk | Image Credit: © Graphicroyalty – © Graphicroyalty – stock.adobe.com.

    The odds of breast cancer in women aged under 55 years are reduced by treatment with unopposed estrogen hormone therapy (E-HT) vs no hormone therapy, according to a recent study published in The Lancet Oncology.1

    Differing risks based on hormone type

    In comparison, the data found increased breast cancer risk in women treated with estrogen plus progestin hormone therapy (EP-HT) vs no hormone therapy. This highlighted different influences on breast cancer risk from 2 common types of hormone therapy, indicating potential guidelines for clinical recommendations about hormone therapy use in young women.1

    “Our study provides greater understanding of the risks associated with different types of hormone therapy, which we hope will help patients and their doctors develop more informed treatment plans,” said Katie O’Brien, PhD, lead author from the National Institute of Health’s National Institute of Environmental Health Sciences (NIEHS).1

    Hormone therapy use in premenopausal women

    The trial was conducted to assess the link between exogenous hormones and breast cancer in young women.2 According to investigators, this population may undergo hormone therapy as management of premenopausal symptoms or following gynecological surgery.

    Women with hysterectomy are the only population recommended to receive E-HT because of the link with uterine cancer risk.1 However, oophorectomy may lead to E-HT or EP-HT use, alongside menopause symptom onset.

    Global data and risk assessment

    Data was obtained from 10 to 13 prospective cohorts in North America, Asia, Europe, and Australia. Participants underwent follow-up to identify breast cancer incidence while aged under 55 years.2

    Hazard ratios (HRs), were determined through cohort-stratified, multivariable-adjusted Cox proportional hazards regression. Additionally, investigators evaluated risk differences based on cumulative risk until age 55 years.2

    Hormone therapy usage and outcomes

    There were 459,476 women aged 16 to 54 years included in the analysis. Young-onset breast cancer was reported in 2% of these patients across a median of 7.8 years. Hormone therapy was reported in 15%, with EP-HT reported in 6% and E-HT in 5%. These were the 2 most common types of hormone therapy used in the study cohort.2

    In non-users, a cumulative risk of 4.1% was reported for breast cancer. Incident young-onset breast cancer risk was not significantly impacted by hormone therapy overall with an HR of 0.96. However, E-HT use was linked to a decreased risk, with an HR of 0.86.2

    For EP-HT use, the risk was increased vs no hormone therapy, with an HR of 1.10. When EP-HT was used for over 2 years, the HR increased to 1.18, highlighting positive associations with long-term use. Similarly, and HR of 1.15 was reported for EP-HT use in women without hysterectomy or bilateral oophorectomy.2

    Subtype-specific risks and clinical implications

    Similar links were reported for all breast cancer subtypes. However, EP-HT use had more significant associations with estrogen receptor-negative and triple-negative disease than other subtypes, with HRs of 1.55 and 1.50, respectively.2

    Overall, the results indicated reduced odds of young-onset breast cancer from E-HT but increased odds from EP-HT. Investigators concluded this data can be used to develop clinical guidelines for hormone use in younger women.

    “Women and their health care providers should weigh the benefits of symptom relief against the potential risks associated with hormone therapy, especially EP-HT. For women with an intact uterus and ovaries, the increased risk of breast cancer with EP-HT should prompt careful deliberation,” said Dale Sandler, PhD, senior author and NIEHS scientist.

    References

    1. Breast cancer risk in younger women may be influenced by hormone therapy. National Institutes of Health. June 30, 2025. Accessed July 8, 2025. https://www.eurekalert.org/news-releases/1088954?
    2. O’Brien KM, House MG, Goldberg M, et al. Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group. The Lancet Oncology. 2025;26(7):911-923. doi:10.1016/S1470-2045(25)00211-6

    Continue Reading

  • PAHO launches new interactive dashboard to monitor respiratory viruses in the Americas – PAHO/WHO

    PAHO launches new interactive dashboard to monitor respiratory viruses in the Americas – PAHO/WHO

    Washington, D.C., July 8, 2025 (PAHO)—The Pan American Health Organization (PAHO) has launched a new interactive dashboard to enhance monitoring and analysis of respiratory virus circulation trends across the Americas, with the goal of strengthening surveillance and facilitating timely analysis of regional trends.

    This interactive dashboard presents virological data (from FluNet) and epidemiological data (from FluID) available through the regional data hub (AMart), providing an intuitive, multilingual platform for exploring key indicators.

    The dashboard features three main sections:

    • Virologic Surveillance presents percent positivity and laboratory sample data for all countries and subregions, enabling detailed tracking of virus circulation patterns.
    • Syndromic Surveillance: displays data on reported cases of severe acute respiratory infection (SARI) and influenza-like illness (ILI), along with intensive care unit (ICU) admissions and SARI-related deaths, offering insights into the clinical presentation of circulating respiratory viruses.
    • Country Profiles: allows users to select any country in the Americas and view all related virologic and syndromic surveillance data on a single, integrated page.

    All dashboard visualizations are interactive, customizable by time period, and available in Spanish, English, French, and Portuguese. The tool is updated weekly and is intended for public health professionals, health authorities, and other stakeholders involved in respiratory virus surveillance.

    In addition, the dashboard includes a feature that provides access to an updated regional summary of the virological situation. As of epidemiological week 25 of 2025 (June 15–21), the data show that the circulation of influenza and respiratory syncytial virus (RSV) aligns with historical seasonal patterns, with high activity in the Southern Hemisphere and low activity in the Northern Hemisphere. For SARS-CoV-2, no defined seasonality is observed; however, circulation remains low in most subregions, except for the Caribbean, where higher activity has been detected.

    Country profiles offer a more detailed breakdown of the national situation.

    Desgloce nacional

    For more detailed and up-to-date information on respiratory viruses in the Americas, visit PAHO’s new interactive dashboard.

    Continue Reading

  • The iPhone 17 Air will reportedly feature an all-new blue color

    The iPhone 17 Air will reportedly feature an all-new blue color

    Continue Reading

  • CPEC-BRI and the Turkic States: Strategic Synergy Ahead

    CPEC-BRI and the Turkic States: Strategic Synergy Ahead

    The rapidly evolving geopolitical and geostrategic landscape has heightened the importance of CPEC and the Belt and Road Initiative (BRI), positioning them as key drivers of socio-economic integration and trans-regional connectivity.

    These initiatives offer a stabilizing framework amid rising uncertainties in the Middle East, the potential closure of the Strait of Hormuz, growing instability in the Arabian Sea, NATO’s eastward expansion in the Black Sea, US-led encirclement of China in the Asia-Pacific, the strategic race for port control in Latin America and India’s hegemonic ambitions in South Asia. As a result, the global contest over economic corridors has intensified.

    Obviously, the CPEC and the Organization of Turkic States (OTS) have immense potential for financial integration, infrastructure development, trade, investment, joint venture and cooperation in qualitative industrialization. Hence both have potential for collaboration which should be tapped in the days to come providing an alternative route in Eurasia and beyond through Gwadar and Karachi dry port and keen interest of all the Central Asian countries mainly Azerbaijan, Uzbekistan, Kazakhstan, Tajikistan and Kyrgyzstan in Gwadar and moreover invitation to Türkiye in CPEC projects vividly reflecting bright prospects of amalgamation of both in the days to come.

    Evidently, CPEC emphasizes infrastructure development and economic cooperation between China and Pakistan, while the OTS promotes cooperation among Turkic states across various sectors. It seems that there is potential for synergy in areas like transportation, maritime cooperation, energy & food and trade, particularly as both initiatives involve countries in Central Asia.

    Similarly, the BRI aims to establish six main economic corridors. One of these corridors is China Central Asia West Asia Economic Corridor (CCWAEC), which begins in China’s Xinjiang Uygur Autonomous Region and spans 17 West Asian nations, including Iran, Saudi Arabia and Türkiye and five Central Asian nations, namely Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan and Turkmenistan promoting cooperation between the BRI and OTS further diversifying China’s trans-regional connectivity and strategic partnership options.

    Additionally, the Central Asian Turkic States hold a strategic position for the BRI which has now entered into its second decade. Interestingly, the OTS which was founded in 2019 concurrently with the emergence of the multipolar world, is composed of Azerbaijan, Kazakhstan, Kyrgyzstan, Uzbekistan and Türkiye as members and Turkmenistan, Hungary and Turkish Republic of Northern Cyprus as observer members. Under BRI, transportation and energy corridors will run across Turkic states in this region consolidating partnership with OTS which is a good omen for both.

    Undoubtedly, BRI stands for international cooperation and economic globalization while the OTS is regarded as a significant geostrategic and geopolitical platform. It is predicted that the OTS and its members’ potential collaboration and partnerships with other nations as active participants in BRI will bring about major changes in the international scene.

    On the other hand, the increasing cooperation among Turkic states is a strategic regional response to intensifying great power competition and shifting geopolitical dynamics in Eurasia. Moreover, Pakistan’s foreign policy supports bilateral and trilateral cooperation and diplomatic ties with all Central Asian countries along with Türkiye which will create a matching box of CPEC-BRI and the OTS.

    According to many published reports the OTS is approximately one-fourth the size of Russia and half the size of China, accounting for around three percent of the world’s total land mass highlighting its geographical importance which may be used for further strengthening of trans-regional connectivity and regional cooperation using CPEC-BRI utility in the days to come. The organization also focused on strengthening transport and energy connectivity, particularly along the Trans-Caspian East-West Corridor and fostered cooperation in areas like trade, investment, green and digital transformation.

    In Q1 2025, the aggregate economic output of OTS countries reached approximately USD 593.8 billion, representing 2.1% of global GDP, with a stable average growth rate of 5.04%—more than double the global average of 2.3%—highlighting the region’s vast economic potential. This momentum could be further enhanced through strategic collaboration with CPEC-BRI. Additionally, total trade turnover amounted to USD 369.3 billion, accounting for 4.4% of global trade, underscoring the bloc’s rising trade competitiveness. Key sectors include energy, logistics, manufacturing and agro-exports, where countries like Türkiye, Kazakhstan and Azerbaijan play pivotal roles as transit hubs and export corridors within the evolving Eurasian landscape.

    Ironically, Kyrgyzstan achieved an extraordinary 13.1% year on year expansion, fueled by a surge in agricultural output and rising global demand for raw materials. Close behind were Northern Cyprus (6.4%), Uzbekistan (6.8%) and Turkmenistan (6.3%), all supported by strong public investment, resource sector growth and increasing foreign direct investment transforming their economies and communities towards greater prosperity and progress.

    Kazakhstan and Uzbekistan led OTS growth through structural reforms, major infrastructure projects, and improved regulations, attracting foreign investment in energy, transport, and manufacturing. Kazakhstan saw 5.6% Q1 growth—its best since 2012—driven by oil and infrastructure. With OTS growth outpacing the global 2.3% average, the region’s economic dynamism and Eurasian relevance continue to rise.

    Turkiye, backed by investor confidence and regional integration, highlights the Turkic region’s growing appeal for productive capital, contingent on fiscal and regulatory stability. Meanwhile, green and digital transitions gain traction, with Azerbaijan, Uzbekistan and Kazakhstan leading Q1 2025. Azerbaijan’s COP29-backed Caspian-Black Sea Green Energy Corridor aims to export renewables to Europe using solar, wind and hydrogen resources.

    In summary, the write suggests that OTS policymakers should promote trans-regional connectivity with CPEC-BRI to eliminate Trump-era trade wars and shield their societies from Cold War mentalities and potential military misadventures. The global power shift from West to East positions Türkiye—geo-strategically located at the center—as key to regional realignments. As a bridge between Asia and Europe, Türkiye and the OTS are vital to BRI’s success. Turkiye’s potential BRICS membership and SCO Dialogue Partner status—alongside Russia, China, Iran, and others—underscore its growing geopolitical weight. Its deepening ties with Russia and expanding BRI cooperation with China reinforce this. Meanwhile, the U.S. is re-engaging in Central Asia to secure rare earth resources and counter Russia-China influence, which should alert the OTS. Severing China-Europe ties remains central to U.S. policy, making BRI a target. Still, CPEC-BRI–OTS synergy promises a win-win in connectivity, industrial growth, energy and food security, socio-economic integration, trade, investment, and joint ventures.

    Continue Reading